Clinical Trial Update: Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) [NA]

View source ↗

Summary

Altoida conducted a clinical trial to evaluate its computerized NMI marker as a potential marker for functional impairment in Alzheimer's disease and mild cogni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: Altoida | Conditions: Alzheimer Disease, Mild Cognitive Impairment | NA | Status: COMPLETED | Results posted: 2020-12-16